EUVIMEDEUVIMED entdecken
Fallbericht

Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion

Volha Lenskaya iD, Richard K Yang iD, Woo Cheal Cho iD

Journal of Cutaneous Pathology · 2024

DOI: 10.1111/cup.14607 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Volha Lenskaya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Oncogene Proteins, Fusion, Sweat Gland Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: University of Texas MD Anderson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gene fusions have emerged as crucial molecular drivers of oncogenesis in a subset of cutaneous adnexal neoplasms, including poroid neoplasms and hidradenomas. We present a unique case of primary cutaneous apocrine carcinoma harboring RARA::NPEPPS fusion, broadening the spectrum of fusion‐associated cutaneous adnexal neoplasms. A 77‐year‐old African American male presented with an ulcerated thigh nodule. Histopathologically, the predominantly dermal‐based adenocarcinoma exhibited papillary, micropapillary, cribriform, and solid growth patterns with central comedonecrosis, set in a fibrotic/desmoplastic stroma. Immunophenotypically, the neoplastic cells were positive for CK7, CK19, GATA3, TRPS1, HER2, CK5/6, calretinin, p63, and DPC4 (no loss), while lacking immunoreactivity for CK20, CDX2, TTF1, napsin‐A, PAX8, arginase‐1, adipophilin, NKX3.1, uroplakin II, and D2‐40. The immunoprofile and clinical and radiographic absence of any internal malignancy, including breast carcinoma, except for multiple lymphadenopathy, supported the diagnosis of primary cutaneous apocrine carcinoma. Next‐generation sequencing unveiled the novel RARA::NPEPPS fusion, concurrent ERBB2 amplification, and multiple somatic mutations involving TP53 , CDKN2A , BRCA2 , PIK3CA , PIK3R1 , and others. The patient developed widespread metastases within a year after the initial diagnosis, indicating the tumor's aggressive behavior. This novel fusion, unprecedented in any human malignancies including primary cutaneous adnexal carcinomas, may suggest a potential new subtype within primary cutaneous adnexal carcinoma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaOncogene Proteins, FusionSweat Gland NeoplasmsAgedHumansMaleApocrine GlandsSkin Neoplasms

Stichwörter der Autor:innen

ERBB2 amplificationRARA::NPEPPS fusionadnexal neoplasmnext‐generation sequencingprimary cutaneous apocrine carcinoma

Substanzen

Oncogene Proteins, Fusion

Autor:innen und Institutionen

  • Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: Volha Lenskaya, Richard K Yang, Woo Cheal Cho

Förderung

  • University of Texas MD Anderson Cancer Center

Zitieren

APA

Lenskaya, V., Yang, R. K., & Cho, W. C. (2024). Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14607

Vancouver

Lenskaya V, Yang RK, Cho WC. Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14607

BibTeX
@article{Lenskaya2024,
  author = {Lenskaya, Volha and Yang, Richard K and Cho, Woo Cheal},
  title = {Primary cutaneous apocrine carcinoma with RARA::NPEPPS fusion},
  journal = {Journal of Cutaneous Pathology},
  year = {2024},
  doi = {10.1111/cup.14607}
}
Kostenlos starten →